All Stories

  1. Overcoming multiple myeloma drug resistance in the era of cancer ‘omics’

    Article • Leukemia & Lymphoma, June 2017, Taylor & Francis

    Dr Giada Bianchi

  2. Cell autonomous and microenvironmental regulation of tumor progression in precursor states of multiple myeloma

    Article • Current Opinion in Hematology, July 2016, Wolters Kluwer Health

    Dr Giada Bianchi

  3. Multiple Myeloma

    Article • October 2015, Wiley

    Dr Giada Bianchi

  4. Promising therapies in multiple myeloma

    Article • Blood, June 2015, American Society of Hematology

    Dr Giada Bianchi

  5. Pathogenesis beyond the cancer clone(s) in multiple myeloma

    Article • Blood, April 2015, American Society of Hematology

    Dr Giada Bianchi

  6. Biological and Clinical Implications of Clonal Heterogeneity and Clonal Evolution in Multiple Myeloma

    Article • Current Cancer Therapy Reviews, November 2014, Bentham Science Publishers

    Dr Giada Bianchi

  7. Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back

    Article • CA A Cancer Journal for Clinicians, September 2014, American Cancer Society

    Dr Giada Bianchi

  8. Best Treatment Strategies in High-Risk Multiple Myeloma: Navigating a Gray Area

    Article • Journal of Clinical Oncology, June 2014, American Society of Clinical Oncology (ASCO)

    Dr Giada Bianchi

  9. Candidate genes of Waldenström’s macroglobulinemia: current evidence and research

    Article • The Application of Clinical Genetics, July 2013, Taylor & Francis

    Dr Giada Bianchi

  10. Migration and Homing in Multiple Myeloma

    Article • October 2012, Springer Science + Business Media

    Dr Giada Bianchi

  11. Molecular mechanisms of effectiveness of novel therapies in multiple myeloma

    Article • Leukemia & Lymphoma, September 2012, Taylor & Francis

    Dr Giada Bianchi

  12. High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma

    Article • Leukemia, August 2012, Springer Science + Business Media

    Dr Giada Bianchi

  13. Does My Patient with a Serum Monoclonal Spike have Multiple Myeloma?

    Article • Hematology/Oncology Clinics of North America, April 2012, Elsevier

    Dr Giada Bianchi

  14. Abstract 5669: Mechanisms of activity and drug resistance with proteasome inhibitors in multiple myeloma: Comparison of bortezomib and the investigational drug MLN9708

    Article • Cancer Research, April 2012, American Association for Cancer Research (AACR)

    Dr Giada Bianchi

  15. Cell Trafficking in Multiple Myeloma

    Article • Open Journal of Hematology, February 2012, Ross Science Publishers

    Dr Giada Bianchi

  16. Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications

    Article • Blood, May 2010, American Society of Hematology

    Dr Giada Bianchi

  17. A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma

    Article • Blood, April 2010, American Society of Hematology

    Dr Giada Bianchi

  18. Functional Interaction of Plasmacytoid Dendritic Cells with Multiple Myeloma Cells: A Therapeutic Target

    Article • Cancer Cell, October 2009, Elsevier

    Dr Giada Bianchi

  19. The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibition

    Article • Blood, January 2009, American Society of Hematology

    Dr Giada Bianchi

  20. Targeting the UPS as therapy in multiple myeloma

    Article • BMC Biochemistry, January 2008, Springer Science + Business Media

    Dr Giada Bianchi

  21. Progressively impaired proteasomal capacity during terminal plasma cell differentiation

    Article • The EMBO Journal, February 2006, Springer Science + Business Media

    Dr Giada Bianchi